Maximising the public health benefit of antimalarials.
作者信息
Price Ric N, Douglas Nicholas M
出版信息
Lancet Infect Dis. 2010 Oct;10(10):654-5. doi: 10.1016/S1473-3099(10)70192-4. Epub 2010 Sep 9.
Abstract
摘要
相似文献
1
Maximising the public health benefit of antimalarials.
Lancet Infect Dis. 2010 Oct;10(10):654-5. doi: 10.1016/S1473-3099(10)70192-4. Epub 2010 Sep 9.
2
Affordable medicines facility for malaria.
Lancet Infect Dis. 2009 Jul;9(7):396-7. doi: 10.1016/S1473-3099(09)70158-6.
3
The Global Fund and effective malaria treatment.
Lancet. 2004 Apr 24;363(9418):1396. doi: 10.1016/S0140-6736(04)16057-1.
4
Revolutionary malaria tests have unexpected downsides.
Science. 2017 Aug 11;357(6351):536-537. doi: 10.1126/science.357.6351.536.
5
Public health. Optimizing investments in malaria treatment and diagnosis.
Science. 2012 Nov 2;338(6107):612-4. doi: 10.1126/science.1229045.
6
Amodiaquine and combination chemotherapy for malaria.
Am J Trop Med Hyg. 2005 Nov;73(5):821-3.
7
Malaria. Signs of drug resistance rattle experts, trigger bold plan.
Science. 2008 Dec 19;322(5909):1776. doi: 10.1126/science.322.5909.1776.
8
Health agencies end in-fighting on malaria.
BMJ. 2004 May 8;328(7448):1095. doi: 10.1136/bmj.328.7448.1095.
9
A Temporizing Solution to "Artemisinin Resistance".
N Engl J Med. 2019 May 30;380(22):2087-2089. doi: 10.1056/NEJMp1901233. Epub 2019 Apr 24.
10
Cambodian villagers help to tackle malaria resistance with simple public health measures.
BMJ. 2010 Jul 9;341:c3696. doi: 10.1136/bmj.c3696.
引用本文的文献
1
Plasmodium falciparum gametocyte carriage is associated with subsequent Plasmodium vivax relapse after treatment.
PLoS One. 2011 Apr 20;6(4):e18716. doi: 10.1371/journal.pone.0018716.
本文引用的文献
1
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
Lancet Infect Dis. 2010 Oct;10(10):673-81. doi: 10.1016/S1473-3099(10)70187-0. Epub 2010 Sep 9.
2
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
PLoS One. 2010 Jul 30;5(7):e11880. doi: 10.1371/journal.pone.0011880.
3
Artemisinin combination therapy for vivax malaria.
Lancet Infect Dis. 2010 Jun;10(6):405-16. doi: 10.1016/S1473-3099(10)70079-7.
4
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Antimicrob Agents Chemother. 2010 May;54(5):1762-8. doi: 10.1128/AAC.01135-09. Epub 2010 Mar 1.
5
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
PLoS One. 2009 Nov 17;4(11):e7871. doi: 10.1371/journal.pone.0007871.
6
Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity.
Malar J. 2008 Dec 3;7:249. doi: 10.1186/1475-2875-7-249.
7
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.
PLoS One. 2007 Oct 10;2(10):e1023. doi: 10.1371/journal.pone.0001023.
8
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Lancet. 2007 Mar 3;369(9563):757-765. doi: 10.1016/S0140-6736(07)60160-3.
9
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Lancet. 2006 Jun 24;367(9528):2075-85. doi: 10.1016/S0140-6736(06)68931-9.
10
Tolerance is the key to understanding antimalarial drug resistance.
Trends Parasitol. 2006 Feb;22(2):71-7. doi: 10.1016/j.pt.2005.12.011. Epub 2006 Jan 10.
Zotero 插件